» Articles » PMID: 17593552

Oxidative Stress and Apoptosis: Impact on Cancer Therapy

Overview
Journal J Pharm Sci
Publisher Elsevier
Specialties Pharmacology
Pharmacy
Date 2007 Jun 27
PMID 17593552
Citations 243
Authors
Affiliations
Soon will be listed here.
Abstract

It is well established that some chemotherapeutic agents and radiation therapy generate reactive oxygen species (ROS) in patients during cancer therapy. Free radicals, particularly ROS have been proposed as common mediators for apoptosis. Recent studies have demonstrated that the mode of cell death depends on the severity of the oxidative damage. This review will address some of the current paradigms of oxidative stress, and antioxidants on apoptosis, and discuss the potential mechanisms by which oxidants can regulate apoptotic pathways. It will also review new developments in eliminating cancer cells by selectively inducing apoptosis.

Citing Articles

Adaptive Proteomic Changes in Protein Metabolism and Mitochondrial Alterations Associated with Resistance to Trastuzumab and Pertuzumab Therapy in HER2-Positive Breast Cancer.

Madoz-Gurpide J, Serrano-Lopez J, Sanz-Alvarez M, Morales-Gallego M, Rodriguez-Pinilla S, Rovira A Int J Mol Sci. 2025; 26(4).

PMID: 40004024 PMC: 11855744. DOI: 10.3390/ijms26041559.


Methuosis, Alkaliptosis, and Oxeiptosis and Their Significance in Anticancer Therapy.

Bartoszewska E, Florek K, Zagorski K, Gachowska M, Wietrzyk A, Hutny A Cells. 2025; 13(24.

PMID: 39768186 PMC: 11674267. DOI: 10.3390/cells13242095.


Synergistic anticancer activity of resveratrol with cisplatin and carboplatin in A549 lung adenocarcinoma cells.

Moar K, Brahma M, Pant A, Maruthi M, Maurya P Int J Clin Exp Pathol. 2024; 17(11):411-420.

PMID: 39660333 PMC: 11626289. DOI: 10.62347/RYSQ1416.


Effect of Spicatoside a on Anti-Osteosarcoma MG63 Cells through Reactive Oxygen Species Generation and the Inhibition of the PI3K-AKT-mTOR Pathway.

Yun H, Kim S, Kwon Y, Park K Antioxidants (Basel). 2024; 13(10).

PMID: 39456416 PMC: 11505237. DOI: 10.3390/antiox13101162.


Prognostic and Predictive Markers for Early Stage Triple-Negative Breast Cancer Treated With Platinum-Based Neoadjuvant Chemotherapy.

Zhao Z, Li L, He M, Li Y, Ma X, Zhao B Cancer Med. 2024; 13(20):e70336.

PMID: 39445528 PMC: 11499949. DOI: 10.1002/cam4.70336.